INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10057HMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 1 | $976.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10067WMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 1 | $930.80 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10184BMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $202.49 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10196PMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $186.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
VEDOLIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10384MMP | VEDOLIZUMAB vedolizumab 300 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $2949.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Entyvio |
VEDOLIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10398GMP | VEDOLIZUMAB vedolizumab 300 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $2998.81 | $31.60 | $31.60 |
| Available brands | |||||||
| Entyvio |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10944BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10955NMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10960WMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10961XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
GOLIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11381BMP | GOLIMUMAB golimumab 100 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 5 | $1124.39 | $31.60 | $31.60 |
| Available brands | |||||||
| Simponi |
GOLIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11382CMP | GOLIMUMAB golimumab 100 mg/mL injection, 1 mL pen device (PI, CMI) |
3 | 3 | 0 | $3296.22 | $31.60 | $31.60 |
| Available brands | |||||||
| Simponi |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11459DMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $186.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11461FMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 2 | $930.80 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remsimaa | |||||||
| Renflexisa |
GOLIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11502JMP | GOLIMUMAB golimumab 100 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 1 | $1124.39 | $31.60 | $31.60 |
| Available brands | |||||||
| Simponi |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11796WMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
5 | 5 | 2 | $976.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remsimaa | |||||||
| Renflexisa |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11797XMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $202.49 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Ixifia | |||||||
| Remicadea | |||||||
| Remsimaa | |||||||
| Renflexisa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12325QMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12333DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12334EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12337HMP | ADALIMUMAB adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (PI, CMI) |
1 | 2 | 5 | $649.38 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12339KMP | ADALIMUMAB adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe (PI, CMI) |
3 | 3 | 0 | $2015.19 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12347WMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12350BMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (PI, CMI) |
2 | 2 | 3 | $624.84 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12351CMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (PI, CMI) |
2 | 2 | 5 | $624.84 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12357JMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (PI, CMI) |
2 | 2 | 5 | $624.84 | $31.60 | $31.60 |
| Available brands | |||||||
| Amgevitaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12358KMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12359LMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12370CMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12371DMP | ADALIMUMAB adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (PI, CMI) |
1 | 2 | 3 | $649.38 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12374GMP | ADALIMUMAB adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device (PI, CMI) |
3 | 3 | 0 | $2015.19 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12382QMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12391EMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12412GMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12550MMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 0 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12552PMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 5 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
TOFACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12556WMP | TOFACITINIB tofacitinib 5 mg tablet, 56 (PI, CMI) |
1 | 56 | 3 | $1212.73 | $31.60 | $31.60 |
| Available brands | |||||||
| Xeljanz |
TOFACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12557XMP | TOFACITINIB tofacitinib 5 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $1212.73 | $31.60 | $31.60 |
| Available brands | |||||||
| Xeljanz |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12561DMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL syringe (PI, CMI) |
2 | 2 | 2 | $760.24 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12575WMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 2 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12584HMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 0 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
INFLIXIMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12587LMP | INFLIXIMAB infliximab 120 mg/mL injection, 1 mL pen device (PI, CMI) |
2 | 2 | 5 | $578.68 | $31.60 | $31.60 |
| Available brands | |||||||
| Remsima SC |
TOFACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12588MMP | TOFACITINIB tofacitinib 10 mg tablet, 56 (PI, CMI) |
1 | 56 | 3 | $1981.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Xeljanz |
TOFACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12589NMP | TOFACITINIB tofacitinib 10 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $1981.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Xeljanz |
VEDOLIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12639FMP | VEDOLIZUMAB vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (PI, CMI) |
1 | 2 | 5 | $1748.10 | $31.60 | $31.60 |
| Available brands | |||||||
| Entyvio |
VEDOLIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12644LMP | VEDOLIZUMAB vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (PI, CMI) |
1 | 2 | 0 | $1748.10 | $31.60 | $31.60 |
| Available brands | |||||||
| Entyvio |
VEDOLIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12647PMP | VEDOLIZUMAB vedolizumab 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices (PI, CMI) |
1 | 2 | 0 | $1748.10 | $31.60 | $31.60 |
| Available brands | |||||||
| Entyvio |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13211HMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13213KMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Hadlimaa | |||||||
| Humiraa | |||||||
| Hyrimoza | |||||||
| Yuflymaa |
UPADACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13249HMP | UPADACITINIB upadacitinib 30 mg modified release tablet, 28 (PI, CMI) |
1 | 28 | 5 | $2078.09 | $31.60 | $31.60 |
| Available brands | |||||||
| Rinvoq |
UPADACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13250JMP | UPADACITINIB upadacitinib 15 mg modified release tablet, 28 (PI, CMI) |
1 | 28 | 5 | $1273.11 | $31.60 | $31.60 |
| Available brands | |||||||
| Rinvoq |
OZANIMOD
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13251KMP | OZANIMOD ozanimod 230 microgram capsule [4] (&) ozanimod 460 microgram capsule [3], 7 (PI, CMI) |
1 | 1 | 0 | $589.72 | $31.60 | $31.60 |
| Available brands | |||||||
| Zeposia |
USTEKINUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13255PMP | USTEKINUMAB ustekinumab 130 mg/26 mL injection, 26 mL vial (PI, CMI) |
4 | 4 | 0 | $2291.80 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
UPADACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13256QMP | UPADACITINIB upadacitinib 15 mg modified release tablet, 28 (PI, CMI) |
1 | 28 | 1 | $1273.11 | $31.60 | $31.60 |
| Available brands | |||||||
| Rinvoq |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13261YMP | USTEKINUMAB ustekinumab 90 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 1 | $1002.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
UPADACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13262BMP | UPADACITINIB upadacitinib 45 mg modified release tablet, 28 (PI, CMI) |
1 | 28 | 3 | $2717.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Rinvoq |
UPADACITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13265EMP | UPADACITINIB upadacitinib 30 mg modified release tablet, 28 (PI, CMI) |
1 | 28 | 1 | $2078.09 | $31.60 | $31.60 |
| Available brands | |||||||
| Rinvoq |
OZANIMOD
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13269JMP | OZANIMOD ozanimod 920 microgram capsule, 28 (PI, CMI) |
1 | 28 | 5 | $2221.22 | $31.60 | $31.60 |
| Available brands | |||||||
| Zeposia |
OZANIMOD
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13271LMP | OZANIMOD ozanimod 920 microgram capsule, 28 (PI, CMI) |
1 | 28 | 3 | $2221.22 | $31.60 | $31.60 |
| Available brands | |||||||
| Zeposia |
USTEKINUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13272MMP | USTEKINUMAB ustekinumab 130 mg/26 mL injection, 26 mL vial (PI, CMI) |
4 | 4 | 0 | $2242.92 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13273NMP | USTEKINUMAB ustekinumab 90 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 0 | $1002.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelaraa | |||||||
| Steqeymaa |
ADALIMUMAB
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/01/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14253EMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $624.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Abrilada
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ADALIMUMAB
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/01/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14273FMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 3 | $624.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Abrilada
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ADALIMUMAB
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/01/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14294HMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $624.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Abrilada
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ETRASIMOD
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14600KMP | ETRASIMOD etrasimod 2 mg tablet, 28 (PI, CMI) |
1 | 28 | 3 | $1434.40 | $31.60 | $31.60 |
| Available brands | |||||||
| Velsipity |
ETRASIMOD
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14601LMP | ETRASIMOD etrasimod 2 mg tablet, 28 (PI, CMI) |
1 | 28 | 5 | $1434.40 | $31.60 | $31.60 |
| Available brands | |||||||
| Velsipity |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14918EMP | USTEKINUMAB ustekinumab 90 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 1 | $1002.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Steqeyma |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14996GMP | ADALIMUMAB adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (PI, CMI) |
1 | 2 | 5 | $649.38 | $31.60 | $31.60 |
| Available brands | |||||||
| Humiraa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner
-
SO
Supply OnlyProducts that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.




